RSS

SMILEE (study efficacy and safety of Viaskin milk in milk-induced eosinophilic esophagitis)

The FDA has accepted an investigator-sponsored investigational new drug application for a Phase IIA clinical trial for the potential treatment of milk-induced eosinophilic esophagitis in children using DBV Technologies' Viaskin milk. more

News